MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on June 29, 2004; DOI: 10.1124/mol.104.000687


0026-895X/04/6604-870-879$20.00
Mol Pharmacol 66:870-879, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.000687v1
66/4/870    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Storz, P.
Right arrow Articles by Toker, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Storz, P.
Right arrow Articles by Toker, A.

Activation Loop Phosphorylation Controls Protein Kinase D-Dependent Activation of Nuclear Factor {kappa}B

Peter Storz, Heike Döppler, and Alex Toker

Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts

Activation of the inducible transcription factor nuclear factor {kappa}B (NF-{kappa}B) occurs in cells exposed to oxidative stress, and the serine/threonine kinase protein kinase D (PKD) is critical for signal relay to NF-{kappa}B. We have recently delineated two coordinated events that control PKD activation in response to oxidative stress: phosphorylation at Tyr463 by the tyrosine kinase Abl, and phosphorylation at the activation loop Ser738/Ser742 by the protein kinase C (PKC) isoform PKC{delta}. The result is fully active PKD that controls NF-{kappa}B activation through the I{kappa}B kinase (IKK) complex. Here, we investigate the mechanism by which PKD controls IKK/NF-{kappa}B activation. Resveratrol, a potent antioxidant, blocks both PKD activation and NF-{kappa}B induction. In particular, resveratrol blocked PKD activation loop phosphorylation and activity, and this was caused by a specific inhibition of the Ser738/Ser742 kinase PKC{delta}. On the other hand, resveratrol did not affect Abl kinase activity and had no effect on Tyr463 phosphorylation. Moreover, we show that the mechanism by which resveratrol inhibits NF-{kappa}B is by blocking the translocation of PKD to the IKK complex, specifically by inhibiting Ser738/Ser742 phosphorylation. We therefore propose that rather than acting as an antioxidant, resveratrol specifically blocks oxidative stress-dependent NF-{kappa}B activation by interfering with PKD phosphorylation and association with the IKK complex.


Received March 22, 2004; accepted June 29, 2004

Address correspondence to: Dr. Alex Toker, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215. E-mail: atoker{at}bidmc.harvard.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
H. Doppler and P. Storz
A Novel Tyrosine Phosphorylation Site in Protein Kinase D Contributes to Oxidative Stress-mediated Activation
J. Biol. Chem., November 2, 2007; 282(44): 31873 - 31881.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. T. Chiu, W. Y. Leung, M. P. Moyer, R. M. Strieter, and E. Rozengurt
Protein kinase D2 mediates lysophosphatidic acid-induced interleukin 8 production in nontransformed human colonic epithelial cells through NF-{kappa}B
Am J Physiol Cell Physiol, February 1, 2007; 292(2): C767 - C777.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Lin, M. A. Glenn, R. J. Harris, A. D. Duckworth, S. Dennett, J. C. Cawley, M. Zuzel, and J. R. Slupsky
c-Abl Expression in Chronic Lymphocytic Leukemia Cells: Clinical and Therapeutic Implications.
Cancer Res., August 1, 2006; 66(15): 7801 - 7809.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. Song, J. Li, A. Lulla, B. M. Evers, and D. H. Chung
Protein kinase D protects against oxidative stress-induced intestinal epithelial cell injury via Rho/ROK/PKC-{delta} pathway activation
Am J Physiol Cell Physiol, June 1, 2006; 290(6): C1469 - C1476.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Zhang, S. Zheng, P. Storz, and W. Min
Protein Kinase D Specifically Mediates Apoptosis Signal-regulating Kinase 1-JNK Signaling Induced by H2O2 but Not Tumor Necrosis Factor
J. Biol. Chem., May 13, 2005; 280(19): 19036 - 19044.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Rozengurt, O. Rey, and R. T. Waldron
Protein Kinase D Signaling
J. Biol. Chem., April 8, 2005; 280(14): 13205 - 13208.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. D. Wood, U. Marklund, and D. A. Cantrell
Dual Phospholipase C/Diacylglycerol Requirement for Protein Kinase D1 Activation in Lymphocytes
J. Biol. Chem., February 18, 2005; 280(7): 6245 - 6251.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics